Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdullah Alsultan

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 17, 2026
Comparing the pharmacokinetics of adalimumab originator and biosimilar product in patients with Inflammatory bowel disease or autoimmune diseaseHadeel Drweesh, Amal Alotaibi, Hussain Abdalghani Alqassim, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2019
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose SelectionMohammad H Al-Shaer, Wael A Alghamdi, Abdullah Alsultan, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2020
Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant TuberculosisMohammad H Al-Shaer, Anne-Grete Märtson, Wael A Alghamdi, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2019
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with TuberculosisWael A Alghamdi, Abdullah Alsultan, Mohammad H Al-Shaer, et al.
Plos One|October 12, 2013
Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) studyCaitrin W McDonough, Nancy K Gillis, Abdullah Alsultan, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2021
Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary TuberculosisJu Sang Kim, Yong-Hyun Kim, Sang Haak Lee, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 17, 2026
Comparing the pharmacokinetics of adalimumab originator and biosimilar product in patients with Inflammatory bowel disease or autoimmune diseaseHadeel Drweesh, Amal Alotaibi, Hussain Abdalghani Alqassim, et al.
Antimicrobial Agents and Chemotherapy|May 8, 2019
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose SelectionMohammad H Al-Shaer, Wael A Alghamdi, Abdullah Alsultan, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2020
Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant TuberculosisMohammad H Al-Shaer, Anne-Grete Märtson, Wael A Alghamdi, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2019
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with TuberculosisWael A Alghamdi, Abdullah Alsultan, Mohammad H Al-Shaer, et al.
Plos One|October 12, 2013
Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) studyCaitrin W McDonough, Nancy K Gillis, Abdullah Alsultan, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2021
Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary TuberculosisJu Sang Kim, Yong-Hyun Kim, Sang Haak Lee, et al.
Pageof 7